Yumanitys chief scientific officer is Kenneth Rhodes, Ph.D., who will direct scientific work on the companys integrated platforms as well as on its drug discovery research. Previously vice president of neurology discovery at Biogen Idec, an organization focused on discovery and early development o
Date: Dec 16, 2014
Category: Health
Source: Google
Biotech Entrepreneur Tony Coles Takes Aim At Parkinson's And Alzheimer's
reviously doneYumanity is a research-stage company, whereas Onyx didnt invent compounds but bought and developed cancer drugs others had discovered Coles took the job. He also brought on Kenneth Rhodes, a former Biogen Idec Biogen Idec executive, to serve as Chief Scientific Officer.